Key result
Higher CHA2DS2-VASc score predicts ~35% greater odds of 6-month left ventricular thrombus non-regression.
Why the study?
Left ventricular thrombus in ischemic heart failure carries embolic risk, but tools to anticipate persistence are limited.
Can explainable machine learning models using baseline echocardiographic and clinical markers predict 6-month persistence of left ventricular thrombus and 1-year MACE in patients with ischemic heart failure?
Cohort (n=190)
No
Can explainable machine learning models using baseline echocardiographic and clinical markers predict 6-month persistence of left ventricular thrombus and 1-year MACE in patients with ischemic heart failure?
Odds Ratio: 1.35 (95% CI 1.09–1.69)
p-value: p=0.007
Machine learning models incorporating baseline echocardiographic and clinical markers can effectively stratify the early risk of left ventricular thrombus persistence, complementing clinical decision-making for imaging follow-up.
Left ventricular thrombus (LVT) in ischemic heart failure carries embolic risk; tools to anticipate persistence are limited. We studied 190 consecutive patients with imaging-confirmed LVT managed with guideline-concordant anticoagulation and serial echocardiography. The primary outcome was 6-month non-regression; 1-year MACE was secondary. We combined classical statistics with explainable machine learning. CatBoost yielded the best discrimination for non-regression (CV-AUC 0.76; test accuracy 0.79). SHAP highlighted left atrial diameter, pulmonary artery pressure, platelet count, and LV end-diastolic diameter as leading predictors. For 1-year outcomes, thrombus size and CHA2DS2-VA were independently associated with MACE (logistic AUC 0.71), whereas "regression vs persistence" alone was not. Baseline remodeling and coagulability markers, captured by an interpretable ML model, stratify early risk of LVT persistence and complement clinical decision-making for imaging follow-up and anticoagulation intensity.
No takes yet. Share an insight, caveat, or question.
Yavuz et al. (2026) conducted a cohort in Ischemic heart failure with left ventricular thrombus (n=190). Baseline clinical and echocardiographic predictors (CHA2DS2-VASc score) was evaluated on 6-month non-regression of left ventricular thrombus (OR 1.35, 95% CI 1.09-1.69, p=0.007). A higher baseline CHA2DS2-VASc score independently predicted 6-month left ventricular thrombus non-regression (OR 1.35), and a machine learning model achieved an AUC of 0.76 for non-regression.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: